190 related articles for article (PubMed ID: 33100270)
1. K
Garner BR; Stolarz AJ; Stuckey D; Sarimollaoglu M; Liu Y; Palade PT; Rusch NJ; Mu S
J Pharmacol Exp Ther; 2021 Jan; 376(1):40-50. PubMed ID: 33100270
[TBL] [Abstract][Full Text] [Related]
2. Syntaxin-1A inhibition of P-1075, cromakalim, and diazoxide actions on mouse cardiac ATP-sensitive potassium channel.
Ng B; Kang Y; Xie H; Sun H; Gaisano HY
Cardiovasc Res; 2008 Dec; 80(3):365-74. PubMed ID: 18703534
[TBL] [Abstract][Full Text] [Related]
3. Muscarinic suppression of ATP-sensitive K
Wang B; Murakami Y; Ono M; Fujikawa S; Matsuyama H; Unno T; Naitou K; Tanahashi Y
Am J Physiol Gastrointest Liver Physiol; 2018 Oct; 315(4):G618-G630. PubMed ID: 30001145
[TBL] [Abstract][Full Text] [Related]
4. Cholesterol-enriched diet inhibits cardioprotection by ATP-sensitive K+ channel activators cromakalim and diazoxide.
Csonka C; Kupai K; Bencsik P; Görbe A; Pálóczi J; Zvara A; Puskás LG; Csont T; Ferdinandy P
Am J Physiol Heart Circ Physiol; 2014 Feb; 306(3):H405-13. PubMed ID: 24285110
[TBL] [Abstract][Full Text] [Related]
5. ATP sensitive potassium channel openers: A new class of ocular hypotensive agents.
Roy Chowdhury U; Dosa PI; Fautsch MP
Exp Eye Res; 2017 May; 158():85-93. PubMed ID: 27130546
[TBL] [Abstract][Full Text] [Related]
6. Regulation of myometrial contraction by ATP-sensitive potassium (KATP) channel via activation of SUR2B and Kir 6.2 in mouse.
Hong SH; Kyeong KS; Kim CH; Kim YC; Choi W; Yoo RY; Kim HS; Park YJ; Ji IW; Jeong EH; Kim HS; Xu WX; Lee SJ
J Vet Med Sci; 2016 Aug; 78(7):1153-9. PubMed ID: 27086859
[TBL] [Abstract][Full Text] [Related]
7. Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection.
Garlid KD; Paucek P; Yarov-Yarovoy V; Murray HN; Darbenzio RB; D'Alonzo AJ; Lodge NJ; Smith MA; Grover GJ
Circ Res; 1997 Dec; 81(6):1072-82. PubMed ID: 9400389
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology and structure-activity relationships for KATP modulators: tissue-selective KATP openers.
Atwal KS
J Cardiovasc Pharmacol; 1994; 24 Suppl 4():S12-7. PubMed ID: 7898103
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin Activates Ryanodine Receptors in Rat Lymphatic Muscle Cells to Attenuate Rhythmic Contractions and Lymph Flow.
Stolarz AJ; Sarimollaoglu M; Marecki JC; Fletcher TW; Galanzha EI; Rhee SW; Zharov VP; Klimberg VS; Rusch NJ
J Pharmacol Exp Ther; 2019 Nov; 371(2):278-289. PubMed ID: 31439806
[TBL] [Abstract][Full Text] [Related]
10. Ba2+ differentially inhibits the Rb+ efflux promoting and the vasorelaxant effects of levcromakalim and minoxidil sulfate in rat isolated aorta.
Quast U; Baumlin Y; Loffler C
Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 353(1):86-93. PubMed ID: 8750921
[TBL] [Abstract][Full Text] [Related]
11. K(ATP) channel openers in the trigeminovascular system.
Ploug KB; Amrutkar DV; Baun M; Ramachandran R; Iversen A; Lund TM; Gupta S; Hay-Schmidt A; Olesen J; Jansen-Olesen I
Cephalalgia; 2012 Jan; 32(1):55-65. PubMed ID: 22144717
[TBL] [Abstract][Full Text] [Related]
12. 4-morpholinecarboximidine-N-1-adamantyl-N'-cyclohexylhydrochloride (U-37883A): pharmacological characterization of a novel antagonist of vascular ATP-sensitive K+ channel openers.
Meisheri KD; Humphrey SJ; Khan SA; Cipkus-Dubray LA; Smith MP; Jones AW
J Pharmacol Exp Ther; 1993 Aug; 266(2):655-65. PubMed ID: 8355199
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of liver regeneration by adenosine triphosphate-sensitive K⁺ channel opener (diazoxide) after partial hepatectomy.
Nakagawa Y; Yoshioka M; Abe Y; Uchinami H; Ohba T; Ono K; Yamamoto Y
Transplantation; 2012 Jun; 93(11):1094-100. PubMed ID: 22466787
[TBL] [Abstract][Full Text] [Related]
14. Kir6.1-dependent K
Davis MJ; Kim HJ; Zawieja SD; Castorena-Gonzalez JA; Gui P; Li M; Saunders BT; Zinselmeyer BH; Randolph GJ; Remedi MS; Nichols CG
J Physiol; 2020 Aug; 598(15):3107-3127. PubMed ID: 32372450
[TBL] [Abstract][Full Text] [Related]
15. Binding and effects of KATP channel openers in the vascular smooth muscle cell line, A10.
Russ U; Metzger F; Kickenweiz E; Hambrock A; Krippeit-Drews P; Quast U
Br J Pharmacol; 1997 Nov; 122(6):1119-26. PubMed ID: 9401776
[TBL] [Abstract][Full Text] [Related]
16. Potassium channel opening drugs and the airways.
Small RC; Berry JL; Foster RW
Braz J Med Biol Res; 1992; 25(10):983-98. PubMed ID: 1342832
[TBL] [Abstract][Full Text] [Related]
17. Lack of effect of potassium channel openers on ATP-modulated potassium channels recorded from rat ventromedial hypothalamic neurones.
Sellers AJ; Boden PR; Ashford ML
Br J Pharmacol; 1992 Dec; 107(4):1068-74. PubMed ID: 1467829
[TBL] [Abstract][Full Text] [Related]
18. Myorelaxant action of fluorine-containing pinacidil analog, flocalin, in bladder smooth muscle is mediated by inhibition of L-type calcium channels rather than activation of KATP channels.
Philyppov IB; Golub AА; Boldyriev OI; Shtefan NL; Totska K; Voitychuk OI; Shuba YM
Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):585-92. PubMed ID: 26976335
[TBL] [Abstract][Full Text] [Related]
19. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
Nielsen-Kudsk JE
Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of etomidate and midazolam on vascular adenosine triphosphate-sensitive potassium channels: isometric tension and patch clamp studies.
Nakamura A; Kawahito S; Kawano T; Nazari H; Takahashi A; Kitahata H; Nakaya Y; Oshita S
Anesthesiology; 2007 Mar; 106(3):515-22. PubMed ID: 17325510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
